Oxcarbazepine Suspension
Product Images NDC 69452-125

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 69452-125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

This is a description of Oxcarbazepine, an oral suspension medication. It is distributed by Bionpharma in Princeton. It must be shaken before use and used within 7 weeks of first opening. It is important to dispense a medication guide to each patient. Each 5 mL contains 300 mg of Oxcarbazepine, USP. The medication must be stored below 30°C and kept away from children. Dosage information is available in the package insert.*

FDA Label Image

Structural Formula (Image01)

FDA Label Image

Image 5 (Image010)

FDA Label Image

Image 6 (Image011v2)

FDA Label Image

Image 7 (Image012v2)

FDA Label Image

Image 8 (Image013v2)

FDA Label Image

Image 9 (Image014v2)

FDA Label Image

Image 10 (Image015v2)

FDA Label Image

Figure 1 (Image02)

This appears to be a table with three columns. The third column contains two groups, "Oxcarbazeping" and "Placebo", likely for a study or clinical trial. The first column has a header that reads "Log-rarkcres", though it is unclear what this refers to. The second column may have to do with the timing of measurements or observations, as it contains a "Time on Tl fom Dy (8ays)" header. Beyond this, the text is not very clear.*

FDA Label Image

Figure 2 (Image03)

FDA Label Image

Figure 3 (Image04)

FDA Label Image

Figure 4 (Image05)

FDA Label Image

Image 1 (Image06)

FDA Label Image

Image 2 (Image07v2)

FDA Label Image

Image 3 (Image08)

FDA Label Image

Image 4 (Image09)

FDA Label Image

Image Description (Revisedimage016)

BIONPHARMA manufactures an oral suspension medication called Oxcarbazepine. The medication is packed in a bottle of 250 ml and its NDC is 69452-125-50. Pharmacists are advised to dispense a Medication Guide enclosed with the medication to each patient. It is important to shake the bottle well before using. The medication should be used within 7 weeks of first opening the bottle. The label suggests that this is a prescription-only medication manufactured by BIONPHARMA located in Princeton, NJ 08540.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.